NEW YORK, June 9, 2026 — Pogo today launched the world’s first AI researcher that puts brands in direct conversation with thousands of purchase-verified buyers of any product. All in a matter of hours, at a scale never before possible.

The company also announced that it has raised $32 million in funding to date from leading investors, founders and creators, including Josh Buckley (Buckley Ventures), Mantis (The Chainsmokers), 20VC (Harry Stebbings), Village Global, Lenny Rachitsky, the founders of Honey, and more.

Founded in 2020, Pogo operates a consumer app with 3 million opted-in U.S. users, with visibility into 1 in every 150 U.S. shopping trips – across $470+ billion in transaction value. Brands tap this network to reach and understand real customers through AI-moderated interviews, quantitative surveys, and always-on behavioral intelligence.

The Pogo app has been rated the #1 loyalty app in the U.S. by Newsweek two years running, because it helps everyday people earn money from their own data. Millions of Americans are able to earn and save hundreds of dollars a year by sharing their data, including card transactions, digital and physical receipts, app usage, and location visits – with transparent controls over which data use cases they participate in. Pogo users also save automatically via fee refunds, class action settlements, insurance savings, and more.

Traditional consumer research has long been plagued by issues with fraud, overrun by survey bots and people lying to qualify for interviews. Brands making billion dollar decisions based on data that they can’t trust. And consumers haven’t fared much better – sitting through endless screener questions, only to get disqualified before the study begins. It’s a broken experience on both sides. Pogo was built to fix that.

Pogo gives brands the ability to talk to real, purchase-verified respondents based on observed SKU-level transaction data, at a level of granularity that’s never existed before: buyers of a product that just launched in stores last week, or a high-value customer who just churned to a competitor.

In the Pogo Platform, brands simply type the audience they want to reach. Pogo’s AI finds the right people in the Pogo network, generates a discussion guide, launches thousands of AI-moderated video interviews simultaneously, and delivers transcripts, highlight reels, and actionable insights in hours. Brands can also run quantitative surveys against the same audiences. Always-on triggers can automatically engage consumers the moment behaviors change, capturing feedback while decisions are still fresh.

Dozens of the world’s largest consumer brands, consulting firms, and investment funds already use Pogo to drive measurable impact.

“Prior to Pogo, the platform we were using had a couple of limitations. We really didn’t have confidence in the output of those surveys because people could tell you whatever they wanted in order to qualify,” said Shannon Clayton, Head of Private Label Marketing at OFI, a $20B private label food manufacturer. “With Pogo’s receipt verification, we felt so much more confident in the data. We presented the information internally and immediately made a business decision. That doesn’t usually happen. Ultimately, that’s going to lead to a multi-million dollar business impact for us.”

Client applications span every category where consumer behavior matters:

• A leading CPG interviewed buyers of a newly launched product, uncovered packaging flaws, and quickly adjusted its supply chain before broader rollout
• A top tech company interviewed robotaxi users to understand why some ride again – and why others churn after their first ride
• A Fortune 500 food manufacturer built a data-backed multi-year view of how GLP-1s are changing what people buy
• A leading investor used Pogo to identify paying Gen Z subscribers of an AI tool as part of investment due diligence

As AI exhausts public data, the real competitive advantage for brands will be high-fidelity consumer feedback.

“If we do our job right, Pogo becomes the world’s most trusted source of human truth. The facts of what people bought, when, and how often, but also the story behind it: the emotion, the context, what drove them,” said co-founder and CEO Dom Wong. “The result is a better system for all sides: smarter decisions for businesses, better products and services for consumers, and a new way for people to earn by sharing their lived experiences.”

About Pogo

Pogo is an AI research platform powered by purchase-verified consumer data. Through its consumer app, more than 3 million opted-in Americans earn money from their own data by sharing transactions, receipts, app usage, and location visits. Brands use Pogo to reach verified buyers through AI-moderated interviews, quantitative surveys, and always-on behavioral intelligence. With visibility into 1 in every 150 U.S. shopping trips, Pogo helps companies understand the people behind every purchase. Pogo has raised $32 million in funding and was founded in 2020 by Oskar Melking, Shikhar Mohan, and Dom Wong. Learn more at joinpogo.com.

SOURCE Pogo Technologies

Supports newly public companies like Neptune Insurance Holdings Inc. following its NYSE listing

CHICAGO, June 9, 2026 — Vinyl Equity, a financial technology infrastructure company for capital markets and corporate transactions and SEC-registered transfer agent, today announced a $20 million Series A led by Jump Capital, with strategic participation from MUFG Innovation Partners (MUIP, the corporate venture capital arm of Mitsubishi UFJ Financial Group) and continued backing from Index Ventures, Spark Capital, Infinity Ventures, and Cambrian Fintech.

The funding comes at a time of rapid innovation across the capital markets, as companies look to improve how they connect to and operate within them. As ownership models evolve, legacy infrastructure is increasingly being replaced, exposing the limitations of disconnected systems and manual processes and creating operational risk for issuers.

“The frustration we hear from issuers is consistent,” said Rob Schoder, CEO and Co-Founder of Vinyl Equity. “The systems they use to interact with the capital markets were built for a different era, and the workarounds that held things together no longer scale. We’re delivering adaptable infrastructure that solves immediate needs for issuers and their shareholders to ensure they’re prepared now and for the next evolution.”

Replacing Legacy Capital Markets Infrastructure
Vinyl replaces legacy workflows with modern systems that deliver real-time accuracy, auditability, and control across the full lifecycle of capital markets and corporate transactions in private and public markets, including shareholder recordkeeping, equity operations, paying agency, and transaction workflows.

Vinyl’s payments solutions offer compliant, secure distributions through a single integrated workflow, enabling issuers to execute distributions at scale without introducing additional intermediaries or manual reconciliation. Built with integrated document collection, KYC/KYB controls, tax filing, audit trails, and fraud prevention at the workflow layer, the platform replaces paper-based processes with a streamlined digital experience designed for the regulatory requirements of modern capital markets.

Vinyl is also deepening its capabilities through integrations with leading equity plan administrators. By connecting transfer agency and equity plan administration through APIs, vested and exercised shares are issued and reconciled in real time, eliminating manual data entry and settlement delays that have historically defined the category and, in some cases, led to costly delays for plan participants.

Vinyl’s infrastructure is designed not just for the issuer, but for every participant in the capital markets ecosystem including equity plan administrators, corporate counsel, brokers, and shareholders.

“We made deliberate architectural choices to ensure Vinyl could operate reliably in regulated, high-stakes market environments,” said Poornaprajna Udupi, CTO and Co-Founder of Vinyl Equity. “That meant prioritizing consistency, auditability, and system integrity across the entire issuer lifecycle from the start so that core workflows function predictably under real market conditions—and the foundation is already in place for what comes next.”

Issuers Seeking Technology Forward User Experience
Vinyl is already supporting a growing roster of publicly traded and private companies across capital markets and corporate transactions. Among them is Neptune Insurance Holdings Inc., for which Vinyl served as transfer agent following its listing on the New York Stock Exchange, managing shareholder onboarding, recordkeeping, and transaction processing.

“Vinyl’s technology-forward approach gave us confidence we had a partner built for where capital markets are going, not where they’ve been,” said Jim Steiner, Chief Operating and Chief Financial Officer of Neptune Insurance Holdings Inc. “As we entered the public markets, we needed a partner that could handle complexity without introducing operational risk, and that’s exactly what Vinyl delivered.”

Positioned for Market Evolution
As capital markets continue to evolve, infrastructure must be able to adapt to new models of ownership and participation without requiring fundamental redesign. That shift is already underway, with emerging models such as tokenization beginning to reshape how ownership is recorded and transferred across markets.

“Core infrastructure in capital markets has remained largely unchanged for decades, even as the demands on those systems have grown significantly,” said Yelena Shkolnik, Partner at Jump Capital. “The tokenization of securities is not a future scenario, it is an active development that most of the existing infrastructure is unprepared for. Vinyl’s platform is already operating in today’s markets while positioned to support how capital markets will continue to evolve.”

Vinyl will use the Series A to expand its engineering, compliance, and go-to-market teams, accelerating infrastructure development across capital markets and corporate transactions, deepening support for issuers across private and public markets, and building the systems that will underpin compliant operations as regulatory frameworks develop.

To learn more about Vinyl Equity, visit www.vinylequity.com.

ABOUT VINYL EQUITY
Vinyl Equity is building modern infrastructure for capital markets and corporate transactions. The company supports public and private companies in IPOs, mergers and acquisitions, equity plan administration, and ongoing issuer operations as an SEC-registered Transfer Agent. Vinyl is backed by Jump Capital, MUFG Innovation Partners , Index Ventures, Spark Capital, Infinity Ventures, and Cambrian Fintech.

SOURCE Vinyl Equity

Backed by Precursor Ventures, Acumen Americas, and Bloomerang founder Jay Love, the newly relaunched platform serves more than 200,000+ beneficiaries across 36 partner organizations nationwide – boasting 100% retention rate

OAKLAND, Calif., June 9, 2026 — Campground, the purpose-built operations platform for social impact programs, today announced that it has raised over $2.2 million to date from Precursor Ventures, Acumen Americas, Underdog Labs, Access Georgia Foundation, Bloomerang founder Jay Love and angel investors.

Workforce development, human services, and community-based programs deliver vital services across the country, but the tools they rely on weren’t designed for their work. Generic CRMs, disconnected spreadsheets, and costly custom-built systems drain staff capacity, fragment critical data, and make it nearly impossible to demonstrate outcomes to funders and policymakers. At a time of deeper funding cuts and increasing demand, staff are spending hours wrangling data instead of focusing on the people they serve.

Campground replaces that patchwork with a single, purpose-built platform that handles participant tracking, employer engagement, task management, and real-time reporting – now enhanced with AI tools designed to help staff work faster without replacing the human judgment their programs depend on – at a fraction of the cost of legacy alternatives.

“As a former nonprofit program leader and board member, I’ve seen frontline staff delivering extraordinary results every day, but they’re wrestling with tools that were never built for them,” said Sruti Bharat, Founder and CEO of Campground. “In this time of budget cuts, staff don’t have the capacity to spend hours entering and cleaning data; they should be out in their communities providing services. With this funding and a new product foundation for responsible AI usage, Campground is making it possible for organizations to scale their work, report on outcomes, and raise more money – without spending six figures and years on tech projects.”

In East Oakland, the Career Exploration Experience (CEE) – a collaboration between Rise East and the East Oakland Youth Development Center – turned to Campground to replace paper-based workflows, spreadsheet overload, and duplicated data that were straining a rapidly growing program. With Campground, CEE consolidated its application and participant tracking into a single platform with automated workflows, supporting 958 students with work-based learning and coaching, saving $100,000, and achieving a 99% participant satisfaction rate.

“Before Campground, we were managing a growing program with tools that couldn’t keep up,” said Selena Wilson, CEO, East Oakland Youth Development Center. “Now our data is organized, our workflows are more sustainable, and our participants have an interface that is really easy to use. That means we can spend more of our time providing services and less time figuring out logistics.”

In Missouri, the Missouri Works Initiative – in partnership with the Associated General Contractors of Missouri (AGC-MO) – turned to Campground to help address the state’s skilled construction labor shortage. The partnership supports graduates of the Apprenticeship Ready Construction (ARC) program, whose connection to hiring contractors had depended almost entirely on quarterly in-person hiring events. With Campground, contractors now have year-round access to vetted graduate profiles, trade interests, and certifications, while program staff track engagement and outcomes in one platform. Today, 166 ARC graduates and 36 contractors are actively using the system to connect across Missouri.

“When Campground showed up, we knew this is exactly what we were looking for to connect contractors with young people looking for construction jobs,” said Len Toenjes, President, AGC of Missouri.

Campground serves as the digital hub for the initiative: helping employers identify qualified candidates while giving program administrators a centralized platform to manage participant engagement, employer relationships, and workforce outcomes.

Since its founding, Campground has served more than 200,000 beneficiaries across 36 partner organizations, including statewide service corps programs, regional workforce initiatives, and community-based youth development organizations. The platform has delivered over $20 million in technology savings to its partners, boasts 100% enterprise retention, and has helped support 1,400 job placements nationwide. Every organization that has invested in Campground remains a partner today, a testament to Campground’s ability to deliver value to clients.

“Over the decade plus we’ve been investing, we’ve observed the social impact sector underserved by technology for too long,” said Yichen Feng, Investment Director, Acumen Americas. “Sruti and her team understand this market deeply because they’ve lived it. Campground isn’t adapting a tool built for the private sector, it’s purpose-built for the way these programs actually operate. That’s why their partners stay and that’s why we’ve invested in them.”

“Campground is solving a problem with real economic gravity. As nonprofits and government agencies face tightening budgets, proving impact with data is existential, not optional,” said Charles Hudson, Managing Partner and Founder, Precursor Ventures. “Campground is helping create an entirely new class of software buyer in a historically underserved market, and that’s why we invested in the company.”

“I’ve spent my career building technology for the social sector, and I know how rare it is to find a founder who truly understands both the mission and the operational reality,” said Jay Love, Founder of Bloomerang. “Campground is solving one of the biggest infrastructure gaps in this space, and they’re doing it at a price point that makes it accessible to the programs that need it most.”

About Campground
Campground is an operating system for running real-world social impact programs that turns everyday operations — like tracking attendance, engagement, milestones, and outcomes — into clear, credible insight. Built by and for program managers, it brings participants, workflows, and outcomes together in one place so that frontline teams can stop managing tools and start running programs with confidence. What once lived across spreadsheets, inboxes, and drives becomes a structured, searchable, shared system for record. To date, Campground has served more than 200,000 beneficiaries across 36 partner organizations with zero enterprise churn. Learn more at getcampground.com

SOURCE Campground Systems

Insight Partners joins NEA and Madrona as Golden Analytics launches public beta following significant early demand

BELLEVUE, Wash., June 9, 2026 — Golden Analytics, the AI-native analytics platform built to make everyone extraordinary with data, today announced a $14 million seed extension led by Insight Partners, bringing total seed funding to $21 million. The round follows significant early demand for the Bellevue-based company since its April launch from stealth, backed by NEA and Madrona, and coincides with its public beta launch.

Nearly 1,000 companies have requested early access to Golden Analytics in the weeks since launch, reflecting the demand for a new generation of analytics built for the AI era. Golden’s offerings instantly surface insight, patterns, and visualizations the moment users connect their data.

“Our early design partners tell us Golden is faster, more flexible, and more empowering than anything they’ve used,” said Francois Ajenstat, Founder and CEO, Golden Analytics. “We’re hearing from companies of every size and across every industry who are ready for a new generation of analytics built for the AI age, from the ground up.”

Companies already working with Golden are beginning to see the impact of an AI-native approach to analytics.

“At Carta, we analyze a proprietary data set of more than $1.2T in investments to deliver insights to the private markets. As AI reshapes how people access data, we evaluated our legacy stack against AI-native tools looking for faster, deeper analysis without compromising the integrity of our customers’ data,” said Ashley Neville, Director of Insights, Carta. “Golden gave us the confidence to move on from legacy contracts. I can’t wait for our audience to see the new interactive capabilities we’re adding to the Data Desk.”

Insight Partners has backed category-defining data companies for over two decades. Their decision to lead this extension reflects a view that the market is headed toward an inflection point, and that Golden’s architecture is well-positioned to lead it.

“Business intelligence is one of the most critical and entrenched categories in enterprise software, yet BI tools have followed the same playbook for decades,” said Ganesh Bell, Managing Director, Insight Partners. “Rather than retrofit AI onto a legacy product, Golden Analytics is rethinking the blueprint entirely, starting from first principles. Francois and his team combine category expertise with the willingness to start from scratch. We look forward to partnering with them as they scale this next chapter, set to redefine a category ripe for transformation.”

Golden Analytics is an AI-native analytics workspace where AI works directly on the data itself, rather than as a feature added to an older architecture. It connects to existing data sources – cloud warehouses such as Snowflake, Databricks, Google BigQuery, and Amazon Redshift, alongside files like Google Sheets and CSVs – surfaces patterns and insights automatically, and gives every user, whatever their technical background, a path from raw data to a finished analysis in one session.

Golden Analytics is now available in public beta. Sign-up for early access at www.goldenanalytics.com.  

About Golden Analytics
Golden Analytics is an AI-native analytics platform that instantly surfaces insights, patterns, and visualizations the moment you connect your data — eliminating the blank-screen frustration of traditional tools. Built around a unique “slider of autonomy,” it lets users choose exactly how much AI assistance they want, from fully manual exploration to fully automated dashboard creation, while always staying in control. Golden is backed by NEA, Madrona, and Insight Partners. Learn more at www.goldenanalytics.com.

About Insight Partners
Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies that are driving transformative change in their industries. As of December 31, 2025, the firm has over $90B in regulatory assets under management. Insight Partners has invested in more than 900 companies worldwide and has seen over 55 portfolio companies achieve an IPO. Headquartered in New York City, Insight has a global presence with leadership in London, Tel Aviv, and the Bay Area. Insight’s mission is to find, fund, and work successfully with visionary executives, providing them with tailored, hands-on software expertise along their growth journey, from their first investment to IPO. For more information on Insight and all its investments, visit insightpartners.com or follow us on X @insightpartners.

SOURCE Golden Analytics

BERKELEY, Calif., June 9, 2026 — ResVita Bio, a biotechnology company pioneering a topical cell therapy modality where living, genetically engineered bacteria continuously produce protein therapeutics for skin diseases, today announced the appointment of John D. Doux, M.D., M.B.A., to its Board of Directors.

“We are thrilled to welcome John to our Board as ResVita prepares to enter the clinic with RVB-003 in Netherton Syndrome and expands our continuous protein therapy platform across a broad range of chronic and rare skin diseases,” said Amin Zargar, Ph.D., Chief Executive Officer and Co-Founder of ResVita Bio. “John is a respected voice in rare skin disease drug development who has spent years championing the case that the orphan disease model can be applied broadly across dermatology, and that thesis is precisely what our platform is built to deliver. His guidance will be invaluable as we build a pipeline of disease-modifying therapies for patients who have long been overlooked.”

Dr. Doux is a board-certified dermatologist, a Fellow of the American Academy of Dermatology, and a longstanding advocate for advancing novel therapies in rare skin diseases. He serves as an analyst at Palo Alto Investors LP, a physician-led healthcare-focused investment firm, where he has been involved in investments across multiple companies developing and commercializing therapies for rare and serious diseases. Dr. Doux currently serves as a board director for Palvella Therapeutics (Nasdaq: PVLA) and Orvida Pharma (formerly Kamari Pharma), and also serves as a board trustee for the Pachyonychia Congenita Project. He co-founded the Dermatology Summit and the Dermatology Innovation Forum and previously served on the conference’s Board of Directors. He maintained a clinical practice in medical and surgical dermatology from 1999 to 2016.

“ResVita has built a true platform where genetic sequences can be swapped to direct the continuous, local production of different therapeutic proteins at the skin surface,” said Dr. Doux. “That modularity, combined with the platform’s preclinical safety and delivery profile, uniquely positions the company to develop disease-modifying therapies for many rare skin diseases with no approved treatments and profound unmet need. I am pleased to join the Board as ResVita advances RVB-003 toward the clinic, and I look forward to partnering with Amin and the team to help bring these therapies to patients.”

Dr. Doux received his B.S. with Distinction and M.D. from Stanford University and conducted early dermatology research as a Howard Hughes Medical Institute Student Fellow in the laboratory of Dr. David T. Woodley. He completed his internship in internal medicine at Brigham and Women’s Hospital and his dermatology residency at Stanford University Medical Center, where he served as Chief Resident. He also earned an M.B.A. from The Wharton School of the University of Pennsylvania, where he was named a Palmer Scholar.

About ResVita Bio

ResVita Bio is a therapeutics company based in Berkeley, California, developing topical cell therapies for skin diseases. By harnessing genetically engineered, non-pathogenic bacteria to continuously produce therapeutic proteins directly on the skin, ResVita is building a pipeline of disease-modifying therapeutic candidates for patients with serious skin diseases. The Company’s lead investigational therapy, RVB-003, is being developed for Netherton Syndrome, a chronic and life-threatening genetic skin disorder with no FDA-approved therapies, and has received both Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA. This work was partially supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awards 1R43AR082240-01 and 2R44AR082240-02.

Media Contact:

Amin Zargar

510-458-2297

[email protected]

SOURCE ResVita Bio

S3 Ventures & Brick & Mortar Ventures lead Series A as Earlytrade posts 7X US revenue growth; Scott Wolfe, founder of Levelset, joins board

DENVER, June 9, 2026 — Earlytrade, the global fintech platform transforming working capital management for the construction industry, today announced new funding bringing total raised to $25 million, including its Series A round led by S3 Ventures and Brick & Mortar Ventures. Capital is being deployed across two priorities: expanding Earlytrade’s US commercial operations and building agentic AI into the core marketplace infrastructure.

Earlytrade operates a subcontractor payments marketplace that allows general contractors to dynamically trade working capital with their subcontractor base, giving them the ability to secure their supply chains and ensure project outcomes are delivered. Since launching in the US in 2024, the company has achieved 7X revenue growth, grown its network to over 211,000 subcontractors, and facilitated more than $3 billion in early payments globally.

“Every dollar that flows through a construction project passes through a payment bottleneck that has never been solved at scale. Earlytrade has built the infrastructure layer that makes agentic AI in this space possible,” said Charlie Plauche, General Partner at S3 Ventures. “That combination of a proven two-sided marketplace and a genuine AI deployment path is exactly what we look for when we back a category-defining company.”

The US construction industry generates over $2 trillion in output annually, yet subcontractors, who perform the majority of the work, routinely wait 60 to 90 days for payment, creating chronic working capital strain. Earlytrade’s subcontractor payment marketplace addresses this structural disadvantage directly, giving subcontractors control over when and at what rate they access capital already owed to them.

“Subcontractors value having flexibility in how and when they access capital to support their businesses,” said Dave Anderskow, CFO at Power Construction, a general contractor and client of Earlytrade. “Earlytrade’s marketplace allows us to invest in our trade partners’ growth in a way that is both disciplined and sustainable.

Founded in 2018 in Australia, Earlytrade relocated its incorporation to the US this year, protecting investors from an increase in capital gains tax that would have doubled their tax burden.

“Strong US growth has made one thing clear: the time is right to make a significant investment in agentic AI within our subcontractor payments marketplace,” said Guy Saxelby, CEO and Co-founder of Earlytrade. “We’re actively seeking exceptional talent across AI, Product, and Sales. Visit our careers page to learn more.”

Joining the board alongside Plauche are Darren Bechtel of Brick & Mortar Ventures; Scott Wolfe, founder and former CEO of Levelset, which sold to Procore for $500 million; Kevin Halter, former revenue leader at PlanGrid who helped scale revenue from $5 million to $90 million before a $900 million acquisition by Autodesk; and Ben Brahinsky, an M&A and private equity specialist who has advised the Earlytrade board for two years and sits on more than ten construction industry boards.

For more information on Earlytrade and available career opportunities, visit www.earlytrade.com.

About Earlytrade

Earlytrade is a global fintech company transforming how construction and enterprise businesses grow margin and turn finance operations into a profit center. Operating across Australia, New Zealand, the United States, Canada, Ireland, and the United Kingdom, Earlytrade’s suite of solutions, including early payment and progress claim platforms, empowers general contractors and trade partners to improve cash flow, increase profitability, and build more resilient supply chains. Learn more at earlytrade.com.

Media Contact:
Stephanie Hall
Pitch Public Relations
480.363.5371
[email protected]

SOURCE Earlytrade

Financing round led by new investor Viking Global Investors with participation from key existing investors

TEMPE, Ariz., June 9, 2026 — GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, today announced the closing of an oversubscribed $100 millon Series E equity financing. The financing was led by new investor Viking Global Investors with participation from key existing investors, including MVM Partners, Gilde Healthcare, Evidity Health Capital, Medtech Venture Partners and FemHealth Ventures.

“This financing is validation of GammaTile’s potential to be a standard of care treatment for operable brain tumors and will accelerate our ability to bring this important therapy to even more patients,” said Per Langoe, Chief Executive Officer at GT Medical Technologies.

The funds will be used to accelerate investments across commercial and operational initiatives following the release of the final data from the Company’s ROADS randomized controlled trial (RCT) last month. The ROADS RCT studied the use of GammaTile^®, the Company’s FDA-cleared bioresorbable radiotherapy implant, in patients with newly diagnosed brain metastases. The ROADS RCT data was selected for oral presentation at the 2026 American Society of Clinical Oncology (ASCO) conference and demonstrated statistical superiority for GammaTile relative to standard of care; GammaTile reduced the risk of tumor recurrence and death at 12 months by 93% and 41%, respectively.¹

Proceeds from the financing will also support continued expansion of GT Medical Technologies’ recently initiated BRIDGES RCT in patients with newly diagnosed glioblastomas (GBMs).

“We are excited to lead this financing and to work with GT to unlock the potential of GammaTile therapy,” said Jason Rostovsky, a Principal at Viking Global Investors. “GT Medical Technologies’ technology has demonstrated profound clinical impact, and we look forward to supporting the GT Medical Technologies team in improving the treatment algorithm for patients with resectable brain tumors.”

“An oversubscribed financing of this magnitude and the strength of our syndicate provides significant optionality for the Company, allowing us to accelerate the next phase of our growth and make meaningful clinical and operational investments for the future,” added James Leech, Chief Financial & Strategy Officer at GT Medical Technologies.

GammaTile is an innovative form of radiation therapy placed at the time of brain tumor removal surgery, delivering immediate, targeted radiation to the tumor resection site when cancer cells are at their lowest residual levels. Unlike conventional approaches that require delays between surgery and the initiation of radiation therapy to allow for wound healing, GammaTile eliminates this treatment gap by starting treatment immediately. By delivering immediate, concentrated radiation directly at the tumor site, GammaTile maximizes the treatment’s effectiveness against remaining cancer cells and reduces the risk of regrowth.

ROADS RCT data presented at the 2026 ASCO conference demonstrated that the 12-month rate of tumor surgical bed recurrence was dramatically lower with GammaTile at 1.3% compared with standard of care at 15.4% (HR:0.07, p=0.012).¹ Surgical bed recurrence-free survival, defined as the time from surgery to either tumor recurrence or death from any cause, whichever occurred first, was significantly improved with GammaTile, with the median time to an event not reached compared with standard of care at 10.9 months (HR: 0.48, P=0.002).¹ Additionally, 24-month overall survival was 61.7% for GammaTile compared with 35.7% for standard of care (HR: 0.59, p=0.032).¹

Recent GT Medical Technologies Milestones

ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile^® Provides Superior Tumor Control Leading to Patients Living Longer Without Recurrence Compared to Standard of Care in Newly Diagnosed Operable Brain Metastases

Radiation-emitting implant improves outcomes after brain cancer surgery | Reuters

GT Medical Technologies Announces First Patients Treated with GammaTile in the BRIDGES Trial for Newly Diagnosed Glioblastoma

https://www.prnewswire.com/BRIDGESgammatile

About GT Medical Technologies, Inc.

GT Medical Technologies was founded by a dedicated team of tumor specialists to address unmet needs in brain tumor treatment. The Company is committed to improving the lives of patients with brain tumors through innovative solutions that elevate the standard of care.

About Viking Global Investors 

Founded in 1999, Viking Global Investors is a global investment firm with a long-term, fundamental, research-intensive approach to investing. Viking manages $52 billion of capital across public and private investments. Viking has offices in Stamford, New York, Hong Kong, London, and San Francisco, and is registered as an investment adviser with the U.S. Securities and Exchange Commission. For more information, please visit www.vikingglobal.com. 

Safe Harbor Statement

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding our expectations, beliefs, or projections. These forward-looking statements are based on management’s current expectations and involve significant risks and uncertainties that may cause actual results, performance, or achievements to differ materially from those expressed or implied by these forward-looking statements. Such factors and risks which could cause actual results to differ materially from those in the forward-looking statements include, without limitation: regulatory risks such as changing CMS, NRC, FDA rules and regulations impacting clearance and/or reimbursement of indicated products; supply chain disruptions; clinical trial and investigation risks including adverse patient outcomes such as death and other severe complications; cost of capital and inflationary risk of raw materials; legal and regulatory risks associated with potential mergers, acquisitions, investments in joint ventures; other global and regulatory uncertainties. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Reference:
1. Weinberg J. ROADS: A randomized controlled phase 3 trial of resection plus post-operative stereotactic radiation versus resection plus cesium-131tile-based radiation therapy for newly diagnosed brain metastases. Presented at: 2026 American Society of Clinical Oncology Conference; May 30, 2026; Chicago, IL.

Media Contact:
Dawn Fallon
New Dawn Communications
[email protected]
(732) 771-7808

SOURCE GT Medical Technologies

Series E Financing Reflects Sustained Investor Confidence in CeQur’s Commercial Trajectory, Clinical Results, and Growing Demand for a Simpler Approach to Mealtime Insulin

HORW, Switzerland, June 9, 2026 — CeQur, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today announced the close of a $100 million Series E financing round. The investment reflects sustained investor confidence in CeQur’s commercial trajectory, its strong pipeline, and the growing demand for a simpler approach to mealtime insulin. The Series E reflects CeQur’s momentum and marks the beginning of its most ambitious phase of commercial growth.

The $100 million will accelerate growth across every dimension of the commercial operation, and CeQur has the infrastructure to deploy it. The field sales team will expand, deepening relationships with healthcare providers and diabetes care specialists who are looking for a simpler approach to mealtime insulin for their patients. As CeQur Simplicity expands to include extended 7-day wear and both 1-unit and 2-unit options, the company is positioned to meet demand across a broader and growing patient population.

“We have the commercial infrastructure, new clinical evidence. and an exciting pipeline. Now we have the capital to accelerate our growth,” said Bradley Paddock, President and Chief Executive Officer of CeQur. “CeQur Simplicity is ready to reach every patient and physician who wants to simplify their insulin delivery and improve their diabetes management.”

Adoption of CeQur Simplicity is expanding steadily across primary care and endocrinology practices nationwide. Better than 85% of all claims are covered as a pharmacy benefit, with an average copay of less than $45 per month. Clinically, the evidence is equally compelling: nearly 90% of patients reported following their insulin regimen better with CeQur Simplicity¹ compared to multiple daily injections, with significantly improved A1C² and time-in-range outcomes³.

“This financing is a direct reflection of what the CeQur team has built and the confidence our investors have placed in CeQur’s growth trajectory,” said Mike Rubino, Chief Financial Officer of CeQur. “We are grateful for that trust and committed to deploying this capital to deliver on the full potential of CeQur Simplicity for patients, for providers, and for every investor who believes in our mission.”

With new FDA clearances, compelling clinical data, and $100 million in capital, CeQur Simplicity is positioned to ensure that patients who want a simpler approach to insulin delivery have options.

About CeQur Simplicity^™

CeQur Simplicity is a convenient, discreet, and injection-free wearable insulin patch that simplifies mealtime dosing. The patch is clinically proven to improve glycemic control, with patients achieving significantly improved A1C² and time-in-range goals³. For people over 21 years of age with diabetes.

Learn more at MyCeQurSimplicity.com or call 1-888-55-CEQUR.

About CeQur^®

CeQur commercializes advanced, simple-to-use insulin-delivery devices that make it easier for people living with diabetes to adhere to therapy and stay in control of their disease. The Company’s simple, wearable devices provide freedom from multiple daily insulin injections.

1. Zraick V, Dreon D, Nalk R, Shearer D, Crawford S, Bradford J, Levy B. Patient User Experience Evaluation of Bolus Patch Insulin Delivery System. Poster presented at: American Diabetes Association 76th Scientific Sessions; 2016; New Orleans, LA. Abstract 995-P.
2. Bergenstal R, Peyrot M, Dreon D, Aroda V, Bailey T, Brazg R, Frias J, Johnson M, Klonoff D, Kruger D, Ramtoola S, Rosenstock J, Serusclat P, Weinstock R, Naik R, Shearer D, Zraick V, Levy B. 2019. Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen. Diabetes Technology and Therapeutics 21 (5):1-13.
3. Bergenstal R., et al Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles; Journal of Diabetes Science and Technology 1–7, 2021

SOURCE CeQur Corporation

GWACHEON, South Korea, June 8, 2026 — Park Systems Corp. (KOSDAQ: 140860), a global leader in atomic force microscopy (AFM) and nanometrology, today announced the successful completion of a KRW 100 billion (approximately USD 72 million) strategic financing through the issuance of perpetual bonds with warrants, with Kiwoom Securities and Dominus Investment Management each subscribing KRW 50 billion. The proceeds will support the company’s production capacity expansion and broader strategic initiatives as demand for precision nanometrology continues to grow across the semiconductor and advanced materials industries.

The bonds were issued at par with 0% interest for the first three years, followed by a step-up interest structure. Warrants are exercisable from June 8, 2027 to May 8, 2056 at KRW 267,747 per share, and Park Systems retains a call option to repurchase up to 20% of the bonds at par between June 2027 and June 2029.

“This financing reflects the company’s commitment to scaling its manufacturing infrastructure in alignment with increasing market demand,” said Karen Cho, Senior Executive Vice President at Park Systems. “As semiconductor process nodes shrink and advanced packaging architectures grow more complex, the need for sub-nanometer surface metrology has become critical across front-end and back-end semiconductor manufacturing. We believe this investment will strengthen our ability to meet growing customer demand and better serve customers worldwide.”

Park Systems serves leading global chipmakers and research institutions across more than 30 countries. Building on this momentum, Park Systems reported consolidated revenue of KRW 205.6 billion in 2025. With a diversified customer base that includes major semiconductor manufacturers and a growing installed base in academic and industrial research, the company is well-positioned to capitalize on the continued expansion of nanotechnology applications worldwide.

About Park Systems

Park Systems is a global leader in nanometrology, providing advanced measurement solutions for both research and industrial applications. Founded by Dr. Sang-il Park, a contributor to the invention of atomic force microscopy (AFM) at Stanford University, the company has grown through continuous innovation and strategic acquisitions to become a leading force in the global nanometrology industry. Park Systems’ technology portfolio includes AFM, white light interferometry (WLI), digital holographic microscopy (DHM), imaging spectroscopic ellipsometry (ISE), active vibration isolation systems, and solid metal probes. With regional offices across the Americas, Europe, and Asia, Park Systems supports customers in semiconductor manufacturing, materials science, and nanotechnology research.

For more information, visit www.parksystems.com

SOURCE Park Systems Corp.